however, these effects may be attenuated or modified by factors such as treatment modality, oocyte source, and patient selection
Food and Drug Administration will meet in July to discuss easing access to seven peptides, experimental drugs that Health and Human Services Secretary Robert F
It is not currently funded by Pharmac, so patients pay for the medication themselves
GLP-1 therapy success depends on more than medication selectionit requires understanding how individual biology, food choices, and metabolism intersect
Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)
Prior medication tolerance, psychiatric history, seizure risk, and liver function are reviewed carefully